Evidence map›Paper›PMID 27698720›Full record

ArticleExperimental and therapeutic medicine2016

Homocysteine injures vascular endothelial cells by inhibiting mitochondrial activity.

Fengyong Yang, Xiujing Qi, Zheng Gao, Xingju Yang, Xingfeng Zheng, Chonghao Duan, Jian Zheng

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Homocysteine and Mitochondria in Cardiovascular and Cerebrovascular Systems.International journal of molecular sciences · 2020
    Review
  6. Endothelial Cell Metabolism.Physiological reviews · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Fengyong YangIntensive Care Unit, The People's Hospital of Laiwu, Laiwu, Shandong 271199, P.R. China.
Xiujing QiIntensive Care Unit, The People's Hospital of Laiwu, Laiwu, Shandong 271199, P.R. China.
Zheng GaoIntensive Care Unit, The People's Hospital of Laiwu, Laiwu, Shandong 271199, P.R. China.
Xingju YangIntensive Care Unit, The People's Hospital of Laiwu, Laiwu, Shandong 271199, P.R. China.
Xingfeng ZhengBurn Center, Shanghai Hospital, Second Military Medical University, Shanghai 200433, P.R. China.
Chonghao DuanIntensive Care Unit, The People's Hospital of Laiwu, Laiwu, Shandong 271199, P.R. China.
Jian ZhengDepartment of Thoracic Surgery, The People's Hospital of Laicheng, Laiwu, Shandong 271199, P.R. China.
Jinan City People's Hospital · CNSecond Military Medical University · CNZoucheng People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the role of homocysteine (Hcy) in the pathogenesis of pulmonary embolism (PE) and the associated molecular mechanisms in human umbilical vein endothelial cells (HUVECs). Hcy contents were detected with high-performance liquid chromatography. Apoptosis was detected by flow cytometry using Annexin-V staining. Cytochrome

Indexed as

apoptosiscytochrome c oxidasehomocysteinepulmonary embolismvascular endothelial cells

Identifiers

PMID27698720
PMCPMC5038564
OpenAlexW2493493343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.